AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · United States

HB3684

Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023

Status

Pending

2023 Session

IntroducedMay 25, 2023 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Dan Crenshaw (Republican)
Type: Clinical Research
Substances: Psilocybin

Official text

Summary (from PoliPsy)

To direct the Secretary of Defense to establish a grant program for using psychedelic substances to treat certain conditions, and for other purposes.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: congress.gov

Legislative history

May 25, 2023
Referred
May 25, 2023
Referred
May 25, 2023
Introduced

Loading bill…